FDA NDC Directory · JSON-LD · Markdown

OZEMPIC

NDC 0169-1715 · HUMAN PRESCRIPTION DRUG · TABLET

Generic nameoral semaglutide
Labeler / ManufacturerNovo Nordisk Pharmaceutical Industries, LP
Marketing categoryNew Drug Application (innovator) · App NDA213051
Dosage form / routeTABLET · ORAL
Active ingredientsSEMAGLUTIDE (1.5 mg/1)
Marketing started20260427
Package count2

External sources

Source: openFDA. Public-domain (CC0).